Moreover, considering that the reduced M1/M2 ratio has the highest HR (Table 3), this pathological factor might have played a major role in the adverse outcome of MUC2++/+++ ovarian cancer cases. This evidence concerns the gene MUC2 and ovarian carcinoma.